ç±³åœåžå Žå¯ãä»ãåïŒç±³ã€ã©ã³äº€æžãåæ»ãç±³åœæ ªã¯å¯ãä»ãåã«å€åãåæ²¹ã¯æ¥éš°åŸã«åèœ
TradingKey - ç±³ã€ã©ã³äº€æžã®åæ»ã«ãããããããç±³åœæ ªã¯ãã©ãã£ãªãã£ã䌎ããªãããäžæåŸåãç¶æããŠãããäžæ¹ãä»é±ã®ãã€ãã¯å€§æåç€Ÿã®æ±ºç®çºè¡šãé£éŠæºåå¶åºŠçäºäŒïŒFRBïŒã®é婿±ºå®ãæ§ããåžå Žåå è ã¯æ¯èŒçæ éãªå§¿å¢ãä¿ã£ãŠãããç±³åœæ ªã¯æ¥çžŸã«ããè£ä»ããšå€éšã®æ¿çç°å¢ãšãã詊緎ã«çŽé¢ããŠããã

å·çæç¹ã§ã米䞻èŠ3ææ°ã¯å°å¹ ã«äžæãããNasdaq 100å ç©ã¯0.22%é«ãšå匷ãå¢ããç¶æããäžæ¹ãS&P 500ã¯0.04%é«ãããŠå·¥æ¥æ ª30皮平åã¯0.1%å®ãšè»èª¿ã ã£ããã¹ããã¯ã¹æ¬§å·600ææ°ã¯äžãå¹ ãæ¡å€§ããæ¥äžé«å€ãæŽæ°ããã
åæµ·ãã¬ã³ãåæ²¹å ç©ã¯äžæ3%è¶ äžæãããããã®åŸäžãå¹ ãçž®å°ãã1%æªæºã®äžæã«ãšã©ãŸã£ãã
ããã«å ç«ã¡ãã€ã©ã³åŽã®æ å ±çã«ãããšãã€ã©ã³ã¯ä»²ä»è ãéããŠç±³åœã«å¯Ÿãã3段éã®äº€æžæ¡ãäŒããŠããã
åžå Žåå
ã¯ã¢ã«ã³ã ã®æ ªäŸ¡ã¯ç±³æ ªåŒåžå Žã®æéå€ååŒã§10%è¶ äžæãããèåã¢ããªã¹ãã®ãã³ããŒã»ã¯ãªæ°ã¯ãOpenAIãç¬èªã®ã¹ããŒããã©ã³éçºãèšç»ããŠãããã¢ãã€ã«ããã»ããµéçºã§MediaTekãã¯ã¢ã«ã³ã ãšææºããŠãããšæçš¿ãããéç£éå§ã¯2028幎ã«ãªãèŠéãã ã
ãããã³ã€ã³ã¯æææ¥ãäžæ7äž9488ãã«ã®é«å€ãä»ããããããã³ã€ã³ã¯åæ¥ãäžæäžãå¹ ã1.5%è¿ãæ¡å€§ããŠ8äžãã«ã®å€§å°ã«è¿«ãã1æ31æ¥ä»¥æ¥ã®é«å€ãèšé²ãããããã®åŸæ¥åèœãããã€ãŒãµãªã¢ã ããããã³ã€ã³ã«é£åããåããšãªã£ãã
ããŒã±ããã»ãã€ã©ã€ã
ç±³ã€ãŒã©ã€ãªãªãŒãAjax Therapeuticsãæå€§23åãã«ã®çŸéã§è²·åãž
ã€ãŒãã³ã»ãã¹ã¯æ°ã2018幎ã®ãã¹ã©CEOããã©ãŒãã³ã¹ã»ã¢ã¯ãŒãè¡äœ¿ã«åãã宿œåæã«çœ²å
ã€ã©ã³ã®æ å ±çã«ãããšãã€ã©ã³ã¯ä»²ä»è ãéããŠç±³åœã«3段éã®äº€æžæ¡ãäŒéãã
äž»èŠããŒã¿ã»ã€ãã³ãã®ãã¬ãã¥ãŒ
ãã©ã€ãŸã³ã4æ27æ¥ïŒç±³æ±éšæéïŒã«æ±ºç®çºè¡šãž
æ¥éã4æ28æ¥ïŒçŸå°æéïŒã«æ¿çé婿±ºå®ãšçµæžã»ç©äŸ¡æ å¢ã®å±æïŒå±æãªããŒãïŒãçºè¡šãž
ã³ã«ã»ã³ãŒã©ã4æ28æ¥ïŒç±³æ±éšæéïŒã«æ±ºç®çºè¡šãž
ãã¶ã4æ28æ¥ïŒç±³æ±éšæéïŒã«æ±ºç®çºè¡šãž
ãã®ã³ã³ãã³ãã¯AIã䜿çšããŠç¿»èš³ãããæç¢ºãã確èªããŸãããæ å ±æäŸã®ã¿ãç®çãšããŠããŸãã
ããããèšäº











ã³ã¡ã³ã (1)
$ãã¿ã³ãã¯ãªãã¯ããã·ã³ãã«ãå ¥åããŠãæ ªåŒãETFããŸãã¯ãã®ä»ã®ãã£ãã«ãŒã·ã³ãã«ããªã³ã¯ããŸãã